Refine
Has Fulltext
- yes (158)
Is part of the Bibliography
- yes (158)
Year of publication
Document Type
- Journal article (104)
- Doctoral Thesis (47)
- Preprint (2)
- Report (2)
- Review (2)
- Book article / Book chapter (1)
Keywords
- Motoneuron (16)
- Spinale Muskelatrophie (11)
- BDNF (9)
- glycine receptor (9)
- spinal muscular atrophy (6)
- Actin (5)
- CNTF (5)
- SMN (5)
- hyperekplexia (5)
- motoneurons (5)
- neurons (5)
- startle disease (5)
- Ionenkanal (4)
- Maus (4)
- Nervenzelle (4)
- TrkB (4)
- Zellkultur (4)
- amyotrophic lateral sclerosis (4)
- Axon (3)
- Ciliary neurotrophic factor (3)
- Entzündung (3)
- Glycin (3)
- Glycinrezeptor (3)
- Hippocampus (3)
- Hyperekplexie (3)
- Phospholipide (3)
- SMA (3)
- STAT3 (3)
- Spinal Muscular Atrophy (3)
- Stathmin (3)
- ciliary neurotrophic factor (3)
- hippocampus (3)
- motoneuron (3)
- neurology (3)
- neuromuscular junction (3)
- synaptic vesicles (3)
- 3D cell culture (2)
- Apoptosis (2)
- BDNF stimulation (2)
- Bewegungsstörung (2)
- Cell culture (2)
- Cys-loop receptor (2)
- Drosophila melanogaster (2)
- Genexpression (2)
- Microtubules (2)
- Motoneuronenerkrankung (2)
- Myatrophische Lateralsklerose (2)
- NaV1.9 (2)
- Neurobiologie (2)
- Neurotrophic factors (2)
- Nociceptor (2)
- PLEKHG5 (2)
- RNA (2)
- Ribosom (2)
- Sap47 (2)
- Schmerzforschung (2)
- Schmerztherapie (2)
- Signaltransduktion (2)
- Spinal muscular atrophy (2)
- Stat3 (2)
- Synapse (2)
- Taufliege (2)
- Transcription (2)
- autoantibodies (2)
- autophagy (2)
- axons (2)
- binding (2)
- cAMP (2)
- cerebellum (2)
- cortical neurons (2)
- drosophila melanogaster (2)
- fear (2)
- glycine receptor autoantibodies (2)
- glycine uptake (2)
- growth cone (2)
- hnRNP R (2)
- hnRNP-R (2)
- hybridomas (2)
- immunoprecipitation (2)
- intracellular domain (2)
- ion channel (2)
- loss of function (2)
- melt electrowriting (2)
- motoneuron disease (2)
- mouse (2)
- mushroom body (2)
- neurofascin (2)
- neuropathic pain (2)
- neurotrophins (2)
- pain (2)
- phosphorylation (2)
- pmn (2)
- prefrontal cortex (2)
- presynaptic hyperekplexia (2)
- receptor (2)
- spinal cord (2)
- structural disruption (2)
- synaptic inhibition (2)
- synaptic plasticity (2)
- trkB (2)
- 2-pore potassium channel (1)
- 3D cell cultures (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D muscle (1)
- 3D neuronal networks (1)
- 3D tumor model (1)
- 3D-Zellkultur (1)
- 4-HNE (1)
- 7,8-dihydroxyflavone (7,8-DHF) (1)
- 7SK (1)
- ALS (1)
- AMPA (1)
- ASC-1 (1)
- Actin Dynamics (1)
- Aging (1)
- Alpha-synuclein oligomers (1)
- Alzheimer disease (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- Aminobuttersäure <gamma-> (1)
- Aminosäuren (1)
- Amyloid-beta oligomers; (1)
- Amyotrophe Lateralsklerose (1)
- Amyotrophic lateral sclerosis (1)
- Amyotrophic-lateral-sclerosis (1)
- Animal modell (1)
- ApoA-I D-4F (1)
- Asc-1 transporter (1)
- Associative learning (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Autism spectrum disorders (1)
- Autoantikörper (1)
- Axon Branching (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal transport (1)
- Axonaler Transport (1)
- BNDF (1)
- BSTA (1)
- Bag1 (1)
- Bildanalyse (1)
- Biologie (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- C9orf72 (1)
- CNS (1)
- CNTF Sehnerv Retina Degeneration (1)
- CNTF optic nerve retina degeneration (1)
- COVID-19 (1)
- Ca\(^{2+}\)-Imaging (1)
- Ca\(_{v}\)2.2 (1)
- Calcium Imaging (1)
- Caspr2 (1)
- Cav2.2 (1)
- Cells (1)
- Cellular prion protein (1)
- Central nervous system (1)
- Chaperone (1)
- Chaperones (1)
- Co-culture (1)
- Contactin-assoziiertes Protein 2 (1)
- Cytochrom C (1)
- Cytochrom c (1)
- Cytochrome C (1)
- Cytokine (1)
- Cytokines (1)
- DAPI staining (1)
- DNA damage (1)
- DNA repeat expansion (1)
- DRD1 (1)
- DRG (1)
- Deeplearning (1)
- Dentate granule cells (1)
- Diabetic polyneuropathy (1)
- Diabetische Polyneuropathie (1)
- Dorsal root ganglion (1)
- Down syndrome (1)
- Drosophilia (1)
- Dynamics of ribosome assembly (1)
- E06 mAb (1)
- EAE (1)
- EGFR (1)
- ER dynamics in axon terminals (1)
- Embryonalentwicklung (1)
- Endoplasmatisches Retikulum (1)
- Erregbarkeit (1)
- Exercise (1)
- F-actin (1)
- FGF-5 (1)
- Facial Nerve Transection (1)
- Familial Alzheimers-disease (1)
- Fazialisläsion (1)
- Fear conditioning (1)
- Fibroblast Growth Factor (1)
- Funktionsverlust (1)
- GABA receptor (1)
- GABA-A receptor (1)
- GABA-Rezeptor (1)
- GABA\(_{A}\) (1)
- GABA\(_{A}\) receptor (1)
- GDNF (1)
- GPCR (1)
- Gedächtnis (1)
- Geruch (1)
- Glucocorticosteroide (1)
- Glutamatergic synapses (1)
- GlyR receptors (1)
- GlyRs (1)
- Glycintransporter 2 (GlyT2) (1)
- Golgi apparatus (1)
- Golgi-Apparat (1)
- Großhirnrinde (1)
- Guillain-Barre-Syndrome (1)
- H2O2 (1)
- Heterogene Ribonucleoproteine (1)
- Histon-Deacetylase (1)
- ICAM-1 (1)
- IGF-I (1)
- IGF1 (1)
- IgG4 (1)
- Ighmbp2 (1)
- Immunhistochemie (1)
- Immunoblot (1)
- Immunopanning (1)
- Induced pluripotent stem cells (1)
- Induzierte pluripotente Stammzelle (1)
- Inflammatory Pain (1)
- Inhibitorische Synapse (1)
- Inhibitory glycine receptor (1)
- Insulin-like Growth (1)
- Insulin-like-Growth-Factor-Binding-Protein-5 (1)
- Insulinlike Growth Factor (1)
- Integrated Defensive States (1)
- Interaction of 7SK with the Smn complex modulates snRNP production (1)
- Intermediate filaments (1)
- Isomer (1)
- JNK (1)
- Kalyx (1)
- Kalziumkanalagonisten (1)
- Kenyon cells (1)
- Kinasen (1)
- Knockdown (1)
- Knockout (1)
- Konformationsänderung (1)
- Kortikogenese (1)
- Krankheit (1)
- LIFR (1)
- LTP (1)
- Lacking neurofilaments (1)
- Laminin (1)
- Learning and memory (1)
- Lernen (1)
- Lysosomal storage disease (1)
- MAP1B (1)
- MND (1)
- MOC fibers (1)
- Mausmodell (1)
- Migration (1)
- Missense mutation (1)
- Molecular neuroscience (1)
- Morpholino (1)
- Motoneuron disease (1)
- Motoneuron-Krankheit (1)
- Motoneuronenerkrankungen (1)
- Motoneuronerkrankung (1)
- Motoneurons (1)
- Motor behaviour (1)
- Motor neuron disease (1)
- Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors (1)
- Motorische Endplatte (1)
- Mouse model (1)
- Mus spretus (1)
- N-Typ Kalziumkanäle (1)
- N-type calcium channel (1)
- NGF gene family (1)
- NMDAR (1)
- NMJ (neuromuscular junction) (1)
- NMJ–neuromuscular junction (1)
- NTRK fusions (1)
- Natriumkanal (1)
- Nervennetz (1)
- Nervensystem (1)
- Neural Stem Cells (1)
- Neural circuits (1)
- Neurale Stammzellen (1)
- Neuritenwachstum (1)
- Neurodegeneration (1)
- Neurofilament (1)
- Neurogenese (1)
- Neuromuskuläre Endplatte (1)
- Neuronal ceroid lipofuscinosis (1)
- Neuronale Differenzierung (1)
- Neuronale Plastizität (1)
- Neurotropher Faktor (1)
- Neurotrophin (1)
- Neurotrophine (1)
- Object recognition (1)
- Optical coherence tomography (1)
- Oxidized Phospholipids (1)
- P75 Neurotrophin receptor (1)
- PAG (1)
- PDXP inhibitors (1)
- PKB/Akt phosphorylation (1)
- PTEN (1)
- Parkinson’s disease (1)
- Pathologie (1)
- Perianova, Irina (1)
- Periaqueductal gray (1)
- Phosphorylation (1)
- Pilzkörper (1)
- Plasma-membrane (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Progressive motor neuronopathy (1)
- Protein kinase B (1)
- Proteine (1)
- Proteintransport (1)
- Präsynaptische Hyperekplexie (1)
- R-Roscovitine (1)
- RHO (1)
- RNA splicing (1)
- RNA transport (1)
- RNA-binding proteins (1)
- ROCK (1)
- RSK2 (1)
- Raf (1)
- Raf <Biochemie> (1)
- Raf Kinasen (1)
- Raf Kinases (1)
- Raf-Kinase (1)
- Raf-Kinasen (1)
- Reprogrammming (1)
- Retinal degeneration (1)
- Rezeptor (1)
- Rictor-mTOR complex (1)
- Roscovitine (1)
- SAP47 gene (1)
- SARS-CoV- 2 (1)
- SLC6A5 (1)
- SLC7A10 (1)
- SMARD1 (1)
- SMN granules (1)
- SOD1 (1)
- SPAQ (1)
- STAT (1)
- Satellite glial cell (1)
- Schmerz (1)
- Schwann cells (1)
- Sehnerv (1)
- Small fiber Neuropathie (1)
- Small fiber neuropathy (1)
- Smn (1)
- Spinal Muscular-arthropy (1)
- Spinal muscular atrophy (DLC) (1)
- Spinale Muskelathropie (1)
- Spinalganglion (1)
- Spliceosome (1)
- Stammzellen (1)
- Syap1 (1)
- Syap1 knockout (1)
- Syap1 localization (1)
- Synapse-associated protein (1)
- Synapsen assoziiert (1)
- Synaptische Transmission (1)
- T-cadherin (1)
- TBCE (1)
- TRP channel (1)
- TRPA1 (1)
- TRPA1 channel (1)
- Temporal-lobe epilepsy (1)
- Tiermodell (1)
- Tissue Engineering (1)
- Transgenic mice (1)
- Ultraschall (1)
- VCAM-1 (1)
- Valproat (1)
- Valproic acid (1)
- Valproinsäure (1)
- Vascular plasticity (1)
- Viability (1)
- Wachstum (1)
- YB-1 (1)
- Yb1 (1)
- Zelldifferenzierung (1)
- Zentrales Nervensystem (1)
- Zytokine (1)
- actin (1)
- actin messenger RNA (1)
- activation (1)
- adenocarcinoma of the lung (1)
- adsorption (1)
- allosteric modulation (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- amoeboid cell migration (1)
- amygdala (1)
- analgesia (1)
- antibodies (1)
- antigen processing and recognition (1)
- anxiety (1)
- apoptosis (1)
- astrocytes (1)
- autism (1)
- autoantibody (aAb) (1)
- autoimmune antibodies (1)
- autoimmune nodopathy (1)
- axon (1)
- axon growth (1)
- axonal transport (1)
- axonaler Transport (1)
- barrier (1)
- basal ganglia (1)
- behavioral disorders (1)
- beta-actin (1)
- bioimage analysis (1)
- biopsies (1)
- brain (1)
- brain cancer (1)
- breast cancer (1)
- c-Jun (1)
- cadherin-13 (CDH13) (1)
- calcium activity (1)
- calcium channels (1)
- calyx (1)
- cancer (1)
- candidate gene (1)
- cardiology (1)
- cell death (1)
- cell staining (1)
- cells (1)
- cerebral blood flow (1)
- channel (1)
- chick (1)
- choline acetyltransferase (1)
- chronic pain (1)
- ciliary neuron (1)
- ciliary-neurotrophic factor (1)
- circuits and circuit components (1)
- claudin-5 (1)
- click-chemistry (1)
- clinical neurology (1)
- cochlea (1)
- comet assay (1)
- compartimentalized cultures (1)
- contactin (1)
- cortico-striatal synapse (1)
- corticogenesis (1)
- cross-sectional studies (1)
- cytosol (1)
- dSPN (1)
- dSTORM (1)
- deep brain stimulation (1)
- defensive states (1)
- degeneration (1)
- demyelination (1)
- dendrite (1)
- dentate gyrus (1)
- determining gene-product (1)
- direct pathway (1)
- domain (1)
- domain K\(^{+}\) channels (1)
- dominant (1)
- dorsal raphe (1)
- dorsal root ganglion (1)
- durotaxis (1)
- dynamics of ribosomal assembly (1)
- early-onset predictors (1)
- electron tomography (1)
- embryos (1)
- emotional states (1)
- energy metabolism (1)
- enrichment (1)
- epilepsy (1)
- exercise (1)
- extracellular domain (1)
- facial nerve lesion (1)
- factor prevents (1)
- fast decay (1)
- fluorescence in-situ hybridization (1)
- frontotemporal dementia (1)
- fused in sarcoma (1)
- gait (1)
- gel electrophoresis (1)
- gene expression (1)
- gene targeting (1)
- genetic code expansion (1)
- genome wide (1)
- genome-wide association studies (1)
- gephyrin (1)
- glycine receptor (GlyR) (1)
- glycine transporter 2 (1)
- glycogen phosphorylase (1)
- glycogen synthase (1)
- glycolysis (1)
- glycosylation (1)
- glyvine uptake (1)
- granule cells (1)
- hearing loss (1)
- heart rate (1)
- hippocampal neurons (1)
- hnRNP (1)
- hnRNP-Q (1)
- homologous recombination (1)
- human startle disease (1)
- hyaluronic acid (1)
- iPSC (induced pluripotent stem cells) (1)
- immune response (1)
- immune serum (1)
- immunocytochemical analysis (1)
- immunohistochemical (1)
- immunohistochemistry techniques (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- inflammatory neuropathy (1)
- inflammatory pain (1)
- inhibitory snapse (1)
- initiation (1)
- injury (1)
- insulin (1)
- insulin-likegrowth factor I (1)
- interaction partners (1)
- interacts (1)
- interleukin 6 (1)
- interspeific backcross (1)
- intrazelluläre Domäne (1)
- ion channels in the nervous system (1)
- knockout mice (1)
- kompartimentierte Kulturen (1)
- lIF (1)
- larval drosophila (1)
- library screening (1)
- ligand potencies (1)
- linalool (1)
- linalyl acetate (1)
- linkage (1)
- lithium (1)
- local protein synthesis (1)
- locomotion (1)
- loop B (1)
- lung and intrathoracic tumors (1)
- mRNA localization (1)
- machine learning (1)
- macrophages (1)
- mechanisms (1)
- medicine (1)
- memory (1)
- mesencephalic locomotor region (1)
- metastasis (1)
- microscopy (1)
- microtubules (1)
- migraine (1)
- migration (1)
- mild cognitive impairment (1)
- mimetic peptide (1)
- modulation (1)
- molecular mechanisms (1)
- molecular medicine (1)
- molecular neuroscience (1)
- monoclonal antibodies (1)
- morpholino knockdown (1)
- motoneuron (MN) (1)
- motor axon (1)
- motor axons (1)
- motor control (1)
- motor learning (1)
- motor neuron (1)
- motor neuron degeneration (1)
- motor neurons (1)
- motor neuropathy (1)
- mouse model (1)
- movement disorders (1)
- mulitple-sclerosis patients (1)
- musk myasthenia gravis (1)
- mutations (1)
- myelin (1)
- nerve injury (1)
- nerve lesion (1)
- nerve ultrasonography (1)
- nervous system (1)
- neural networks (1)
- neurite (1)
- neurodegeneration (1)
- neurodegenerative disorder (1)
- neurodevelopment (1)
- neurofilaments (1)
- neuroinflammation (1)
- neuron migration (1)
- neuronal dendrites (1)
- neuronal differentiation (1)
- neuronal excitability (1)
- neuronal network (1)
- neuronal networks (1)
- neuronal primary culture (1)
- neuronal survival and differentiation (1)
- neuronale Plastizität (1)
- neuropathy (1)
- neuropil (1)
- neuroscience (1)
- neurotrophe Faktoren (1)
- neurotrophic (1)
- neurotrophic factor (1)
- neurotrophic molecules (1)
- nifedipine (1)
- nociception (1)
- node of ranvier (1)
- non-small cell lung cancer (1)
- nonneuronaI cells (1)
- nuclear ribonucleoprotein-R (1)
- ontactin 1 (1)
- outer hair cell (OHC) (1)
- oxidized phospholipids (1)
- oxygenation (1)
- pain therapy (1)
- passive transfer (1)
- patch clamp recording (1)
- patch-clamp (1)
- pegylated insulin-like growth factor 1 (1)
- periperal nerve (1)
- peripheral neuropathy (1)
- phosphorylase isozymes (1)
- photothrombotic stroke (1)
- pmn-Maus (1)
- postsynaptic potentials (1)
- posttranslational modifications (1)
- prediction error (1)
- presynapse (1)
- presynaptic ER dynamics (1)
- primary notoneuron (1)
- primäre Motoneurone (1)
- programmed cell death (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- protein coupled receptors (1)
- protein interactions (1)
- protein maturation (1)
- protein synthesis (1)
- protein transport (1)
- psychiatric disorders (1)
- pyridoxal phosphatase (PDXP) (1)
- quality control (1)
- radial glia (1)
- rat (1)
- recombinant proteins (1)
- regulation (1)
- rescue (1)
- restriction fragment length polymorphism (1)
- roles (1)
- secondary lung tumors (1)
- self-activation (1)
- sensory neurons (1)
- serotonin (1)
- shaky mouse (1)
- short-term memory (1)
- side chain properties (1)
- silver staining (1)
- site (1)
- skeletal muscle (1)
- snRNP (1)
- sodium channel (1)
- software (1)
- spastic (1)
- spinal cord neurons (1)
- spontaneous excitation (1)
- spontaneous mouse mutants (1)
- startle (1)
- startle reaction (1)
- stathmin (1)
- stiff person syndrome (1)
- stiff-person syndrome (SPS) (1)
- stroke (1)
- subcellular trafficking (1)
- super-resolution microscopy (SRM) (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- survey (1)
- survival (1)
- switch (1)
- synapse structure (1)
- synapses (1)
- synaptic localization (1)
- synaptic proteins (1)
- synaptic transmission (1)
- synaptisches Protein (1)
- synthase (1)
- systems biology (1)
- telemedicine (1)
- therapeutic antibody (1)
- thoracic diaphragm (1)
- tight junction (1)
- topotaxis (1)
- trafficking (1)
- trafficking pathways (1)
- transactivation (1)
- transport (1)
- trophic/potassium deprivation (1)
- tyrosine kinase (1)
- ultrasound (1)
- uper-resolution array tomography (1)
- vasculitis (1)
- vector cloning (1)
- vitamin B6 (1)
- α-synuclein-specific T cells (1)
- β-Aktin (1)
- β-actin (1)
- β-actin mRNA (1)
- β8-β9 loop (1)
Institute
- Institut für Klinische Neurobiologie (158) (remove)
Bioimages frequently exhibit low signal-to-noise ratios due to experimental conditions, specimen characteristics, and imaging trade-offs. Reliable segmentation of such ambiguous images is difficult and laborious. Here we introduce deepflash2, a deep learning-enabled segmentation tool for bioimage analysis. The tool addresses typical challenges that may arise during the training, evaluation, and application of deep learning models on ambiguous data. The tool’s training and evaluation pipeline uses multiple expert annotations and deep model ensembles to achieve accurate results. The application pipeline supports various use-cases for expert annotations and includes a quality assurance mechanism in the form of uncertainty measures. Benchmarked against other tools, deepflash2 offers both high predictive accuracy and efficient computational resource usage. The tool is built upon established deep learning libraries and enables sharing of trained model ensembles with the research community. deepflash2 aims to simplify the integration of deep learning into bioimage analysis projects while improving accuracy and reliability.
The neuronal RNA-binding protein Ptbp2 regulates neuronal differentiation by modulating alternative splicing programs in the nucleus. Such programs contribute to axonogenesis by adjusting the levels of protein isoforms involved in axon growth and branching. While its functions in alternative splicing have been described in detail, cytosolic roles of Ptbp2 for axon growth have remained elusive. Here, we show that Ptbp2 is located in the cytosol including axons and growth cones of motoneurons, and that depletion of cytosolic Ptbp2 affects axon growth. We identify Ptbp2 as a major interactor of the 3’ UTR of Hnrnpr mRNA encoding the RNA-binding protein hnRNP R. Axonal localization of Hnrnpr mRNA and local synthesis of hnRNP R protein are strongly reduced when Ptbp2 is depleted, leading to defective axon growth. Ptbp2 regulates hnRNP R translation by mediating the association of Hnrnpr with ribosomes in a manner dependent on the translation factor eIF5A2. Our data thus suggest a mechanism whereby cytosolic Ptbp2 modulates axon growth by fine-tuning the mRNA transport and local synthesis of an RNA-binding protein.
The signals that coordinate and control movement in vertebrates are transmitted from motoneurons (MNs) to their target muscle cells at neuromuscular junctions (NMJs). Human NMJs display unique structural and physiological features, which make them vulnerable to pathological processes. NMJs are an early target in the pathology of motoneuron diseases (MND). Synaptic dysfunction and synapse elimination precede MN loss suggesting that the NMJ is the starting point of the pathophysiological cascade leading to MN death. Therefore, the study of human MNs in health and disease requires cell culture systems that enable the connection to their target muscle cells for NMJ formation. Here, we present a human neuromuscular co-culture system consisting of induced pluripotent stem cell (iPSC)-derived MNs and 3D skeletal muscle tissue derived from myoblasts. We used self-microfabricated silicone dishes combined with Velcro hooks to support the formation of 3D muscle tissue in a defined extracellular matrix, which enhances NMJ function and maturity. Using a combination of immunohistochemistry, calcium imaging, and pharmacological stimulations, we characterized and confirmed the function of the 3D muscle tissue and the 3D neuromuscular co-cultures. Finally, we applied this system as an in vitro model to study the pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and found a decrease in neuromuscular coupling and muscle contraction in co-cultures with MNs harboring ALS-linked SOD1 mutation. In summary, the human 3D neuromuscular cell culture system presented here recapitulates aspects of human physiology in a controlled in vitro setting and is suitable for modeling of MND.
Human startle disease is associated with mutations in distinct genes encoding glycine receptors, transporters or interacting proteins at glycinergic synapses in spinal cord and brainstem. However, a significant number of diagnosed patients does not carry a mutation in the common genes GLRA1, GLRB, and SLC6A5. Recently, studies on solute carrier 7 subfamily 10 (SLC7A10; Asc-1, alanine-serine-cysteine transporter) knock-out (KO) mice displaying a startle disease-like phenotype hypothesized that this transporter might represent a novel candidate for human startle disease. Here, we screened 51 patients from our patient cohort negative for the common genes and found three exonic (one missense, two synonymous), seven intronic, and single nucleotide changes in the 5′ and 3′ untranslated regions (UTRs) in Asc-1. The identified missense mutation Asc-1\(^{G307R}\) from a patient with startle disease and developmental delay was investigated in functional studies. At the molecular level, the mutation Asc-1\(^{G307R}\) did not interfere with cell-surface expression, but disrupted glycine uptake. Substitution of glycine at position 307 to other amino acids, e.g., to alanine or tryptophan did not affect trafficking or glycine transport. By contrast, G307K disrupted glycine transport similar to the G307R mutation found in the patient. Structurally, the disrupted function in variants carrying positively charged residues can be explained by local structural rearrangements because of the large positively charged side chain. Thus, our data suggest that SLC7A10 may represent a rare but novel gene associated with human startle disease and developmental delay.
Introduction
IgG4 autoantibodies against paranodal proteins are known to induce acute-onset and often severe sensorimotor autoimmune neuropathies. How autoantibodies reach their antigens at the paranode in spite of the myelin barrier is still unclear.
Methods
We performed in vitro incubation experiments with patient sera on unfixed and unpermeabilized nerve fibers and in vivo intraneural and intrathecal passive transfer of patient IgG to rats, to explore the access of IgG autoantibodies directed against neurofascin-155 and contactin-1 to the paranodes and their pathogenic effect.
Results
We found that in vitro incubation resulted in weak paranodal binding of anti-contactin-1 autoantibodies whereas anti-neurofascin-155 autoantibodies bound to the nodes more than to the paranodes. After short-term intraneural injection, no nodal or paranodal binding was detectable when using anti-neurofascin-155 antibodies. After repeated intrathecal injections, nodal more than paranodal binding could be detected in animals treated with anti-neurofascin-155, accompanied by sensorimotor neuropathy. In contrast, no paranodal binding was visible in rats intrathecally injected with anti-contactin-1 antibodies, and animals remained unaffected.
Conclusion
These data support the notion of different pathogenic mechanisms of anti-neurofascin-155 and anti-contactin-1 autoantibodies and different accessibility of paranodal and nodal structures.
Despite fine tuning voluntary movement as the most prominently studied function of the cerebellum, early human studies suggested cerebellar involvement emotion regulation. Since, the cerebellum has been associated with various mood and anxiety-related conditions. Research in animals provided evidence for cerebellar contributions to fear memory formation and extinction. Fear and anxiety can broadly be referred to as defensive states triggered by threat and characterized by multimodal adaptations such as behavioral and cardiac responses integrated into an intricately orchestrated defense reaction. This is mediated by an evolutionary conserved, highly interconnected network of defense-related structures with functional connections to the cerebellum. Projections from the deep cerebellar nucleus interpositus to the central amygdala interfere with retention of fear memory. Several studies uncovered tight functional connections between cerebellar deep nuclei and pyramis and the midbrain periaqueductal grey. Specifically, the fastigial nucleus sends direct projections to the ventrolateral PAG to mediate fear-evoked innate and learned freezing behavior. The cerebellum also regulates cardiovascular responses such as blood pressure and heart rate-effects dependent on connections with medullary cardiac regulatory structures. Because of the integrated, multimodal nature of defensive states, their adaptive regulation has to be highly dynamic to enable responding to a moving threatening stimulus. In this, predicting threat occurrence are crucial functions of calculating adequate responses. Based on its role in prediction error generation, its connectivity to limbic regions, and previous results on a role in fear learning, this review presents the cerebellum as a regulator of integrated cardio-behavioral defensive states.
Glycine receptor (GlyR) autoantibodies are associated with stiff-person syndrome and the life-threatening progressive encephalomyelitis with rigidity and myoclonus in children and adults. Patient histories show variability in symptoms and responses to therapeutic treatments. A better understanding of the autoantibody pathology is required to develop improved therapeutic strategies. So far, the underlying molecular pathomechanisms include enhanced receptor internalization and direct receptor blocking altering GlyR function. A common epitope of autoantibodies against the GlyRα1 has been previously defined to residues 1A-33G at the N-terminus of the mature GlyR extracellular domain. However, if other autoantibody binding sites exist or additional GlyR residues are involved in autoantibody binding is yet unknown. The present study investigates the importance of receptor glycosylation for binding of anti-GlyR autoantibodies. The glycine receptor α1 harbors only one glycosylation site at the amino acid residue asparagine 38 localized in close vicinity to the identified common autoantibody epitope. First, non-glycosylated GlyRs were characterized using protein biochemical approaches as well as electrophysiological recordings and molecular modeling. Molecular modeling of non-glycosylated GlyRα1 did not show major structural alterations. Moreover, non-glycosylation of the GlyRα1N38Q did not prevent the receptor from surface expression. At the functional level, the non-glycosylated GlyR demonstrated reduced glycine potency, but patient GlyR autoantibodies still bound to the surface-expressed non-glycosylated receptor protein in living cells. Efficient adsorption of GlyR autoantibodies from patient samples was possible by binding to native glycosylated and non-glycosylated GlyRα1 expressed in living not fixed transfected HEK293 cells. Binding of patient-derived GlyR autoantibodies to the non-glycosylated GlyRα1 offered the possibility to use purified non-glycosylated GlyR extracellular domain constructs coated on ELISA plates and use them as a fast screening readout for the presence of GlyR autoantibodies in patient serum samples. Following successful adsorption of patient autoantibodies by GlyR ECDs, binding to primary motoneurons and transfected cells was absent. Our results indicate that the glycine receptor autoantibody binding is independent of the receptor’s glycosylation state. Purified non-glycosylated receptor domains harbouring the autoantibody epitope thus provide, an additional reliable experimental tool besides binding to native receptors in cell-based assays for detection of autoantibody presence in patient sera.
Highlights
• Dopamine receptor-1 activation induces TrkB cell-surface expression in striatal neurons
• Dopaminergic deficits cause TrkB accumulation and clustering in the ER
• TrkB clusters colocalize with cargo receptor SORCS-2 in direct pathway striatal neurons
• Intracellular TrkB clusters fail to fuse with lysosomes after dopamine depletion
Summary
Disturbed motor control is a hallmark of Parkinson’s disease (PD). Cortico-striatal synapses play a central role in motor learning and adaption, and brain-derived neurotrophic factor (BDNF) from cortico-striatal afferents modulates their plasticity via TrkB in striatal medium spiny projection neurons (SPNs). We studied the role of dopamine in modulating the sensitivity of direct pathway SPNs (dSPNs) to BDNF in cultures of fluorescence-activated cell sorting (FACS)-enriched D1-expressing SPNs and 6-hydroxydopamine (6-OHDA)-treated rats. DRD1 activation causes enhanced TrkB translocation to the cell surface and increased sensitivity for BDNF. In contrast, dopamine depletion in cultured dSPN neurons, 6-OHDA-treated rats, and postmortem brain of patients with PD reduces BDNF responsiveness and causes formation of intracellular TrkB clusters. These clusters associate with sortilin related VPS10 domain containing receptor 2 (SORCS-2) in multivesicular-like structures, which apparently protects them from lysosomal degradation. Thus, impaired TrkB processing might contribute to disturbed motor function in PD.
In the central nervous system, excitatory and inhibitory signal transduction processes are mediated by presynaptic release of neurotransmitters, which bind to postsynaptic receptors. Glycine receptors (GlyRs) and GABAA receptors (GABAARs) are ligand-gated ion channels that enable synaptic inhibition. One part of the present thesis elucidated the role of the GlyRα1 β8 β9 loop in receptor expression, localization, and function by means of amino acid substitutions at residue Q177. This residue is underlying a startle disease phenotype in the spontaneous mouse model shaky and affected homozygous animals are dying 4-6 weeks after birth. The residue is located in the β8 β9 loop and thus part of the signal transduction unit essential for proper ion channel function. Moreover, residue Q177 is involved in a hydrogen network important for ligand binding. We observed no difference in ion channel trafficking to the cellular membrane for GlyRα1Q177 variants. However, electrophysiological measurements demonstrated reduced glycine, taurine, and β alanine potency in comparison to the wildtype protein. Modeling revealed that some GlyRα1Q177 variants disrupt the hydrogen network around residue Q177. The largest alterations were observed for the Q177R variant, which displayed similar effects as the Q177K mutation present in shaky mice. Exchange with structurally related amino acids to the original glutamine preserved the hydrogen bond network. Our results underlined the importance of the GlyR β8 β9 loop for proper ion channel gating.
GlyRs as well as GABAARs can be modulated by numerous allosteric substances. Recently, we focused on monoterpenes from plant extracts and showed positive allosteric modulation of GABAARs. Here, we focused on the effect of 11 sesquiterpenes and sesquiterpenoids (SQTs) on GABAARs. SQTs are compounds naturally occurring in plants. We tested SQTs of the volatile fractions of hop and chamomile, including their secondary metabolites generated during digestion. Using the patch-clamp technique on transfected cells and neurons, we were able to observe significant GABAAR modulation by some of the compounds analyzed. Furthermore, a possible binding mechanism of SQTs to the neurosteroid binding site of the GABAAR was revealed by modeling and docking studies. We successfully demonstrated GABAAR modulation by SQTs and their secondary metabolites.
The second part of the thesis investigated three-dimensional (3D) in vitro cell culture models which are becoming more and more important in different part of natural sciences. The third dimension allows developing of complex models closer to the natural environment of cells, but also requires materials with mechanical and biological properties comparable to the native tissue of the encapsulated cells. This is especially challenging for 3D in vitro cultures of primary neurons and astrocytes as the brain is one of the softest tissues found in the body. Ultra-soft matrices that mimic the neuronal in vivo environment are difficult to handle. We have overcome these challenges using fiber scaffolds created by melt electrowriting to reinforce ultra-soft matrigel. Hence, the scaffolds enabled proper handling of the whole composites and thus structural and functional characterizations requiring movement of the composites to different experimental setups. Using these scaffold-matrigel composites, we successfully established methods necessary for the characterization of neuronal network formation. Before starting with neurons, a mouse fibroblast cell line was seeded in scaffold-matrigel composites and transfected with the GlyR. 3D cultured cells displayed high viability, could be immunocytochemically stained, and electrophysiologically analyzed.
In a follow-up study, primary mouse cortical neurons in fiber-reinforced matrigel were grown for up to 21 days in vitro. Neurons displayed high viability, and quantification of neurite lengths and synapse density revealed a fully formed neuronal network already after 7 days in 3D culture. Calcium imaging and patch clamp experiments demonstrated spontaneous network activity, functional voltage-gated sodium channels as well as action potential firing. By combining ultra-soft hydrogels with fiber scaffolds, we successfully created a cell culture model suitable for future work in the context of cell-cell interactions between primary cells of the brain and tumor cells, which will help to elucidate the molecular pathology of aggressive brain tumors and possibly other disease mechanisms.